Evidence map›Paper›PMID 41635945›Full record

ArticleResearch synthesis methods2026

Shiny-MAGEC: A Bayesian R shiny application for meta-analysis of censored adverse events.

Zihan Zhou, Zizhong Tian, Christine Peterson, Le Bao, Shouhao Zhou

Abstract read
In one paragraph

Article in Research synthesis methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zihan ZhouPublic Health Sciences, https://ror.org/04p491231Pennsylvania State University, United States.ORCID https://orcid.org/0009-0006-6185-9996
Zizhong TianPublic Health Sciences, https://ror.org/04p491231Pennsylvania State University, United States.
Christine PetersonBiostatistics, https://ror.org/04twxam07The University of Texas MD Anderson Cancer Center, United States.
Le BaoStatistics, https://ror.org/04p491231Pennsylvania State University, United States.
Shouhao ZhouPublic Health Sciences, https://ror.org/04p491231Pennsylvania State University, United States.ORCID https://orcid.org/0000-0002-8124-5047

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
The Penn State Coordinating Center (CC) for the Multi-Sectoral Preventive Interventions (MSPI) Research NetworkU24MD020517 · NIMHD · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHINCHILLI, VERNON M, KRASCHNEWSKI, JENNIFER L. · 2025 to 2025
$3.3M
Meta-analysis of Adverse Drug Effects in Clinical TrialsR21LM014534 · NLM · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI PETERSON, CHRISTINE B, ZHOU, SHOUHAO · 2024 to 2025
$432k
NCI NIH HHS P30 CA016672NCI NIH HHS P30CA016672NIMHD NIH HHS U24 MD020517NIMHD NIH HHS U24MD020517NLM NIH HHS R21 LM014534
6 · The paper itself

Abstract

Accurate assessment of adverse event (AE) incidence is critical in clinical research for drug safety. While meta-analysis serves as an essential tool to comprehensively synthesize the evidence across multiple studies, incomplete AE reporting in clinical trials remains a persistent challenge. In particular, AEs occurring below study-specific reporting thresholds are often omitted from publications, leading to left-censored data. Failure to account for these censored AE counts can result in biased AE incidence estimates. We present an R Shiny application that implements a Bayesian meta-analysis model specifically designed to incorporate censored AE data into the estimation process. This interactive tool provides a user-friendly interface for researchers to conduct AE meta-analyses and estimate the AE incidence probability using an unbiased approach. It also enables direct comparisons between models that either incorporate or ignore censoring, highlighting the biases introduced by conventional approaches. This tutorial demonstrates the Shiny application's functionality through an illustrative example on meta-analysis of PD-1/PD-L1 inhibitor safety and highlights the importance of this tool in improving AE risk assessment. Ultimately, the new Shiny app facilitates more accurate and transparent drug safety evaluations. The Shiny-MAGEC app is available at: https://zihanzhou98.shinyapps.io/Shiny-MAGEC/.

Indexed as

Drug-Related Side Effects and Adverse ReactionsMeta-Analysis as TopicSoftwareAdverse Drug Reaction Reporting SystemsAlgorithmsBayes TheoremComputer SimulationHumansIncidenceModels, StatisticalProbabilityResearch DesignRisk AssessmentUser-Computer InterfaceBayesian inferencedrug safetyincomplete reportingMAGECmeta-analysis

Identifiers

PMID41635945
PMCPMC12873611

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.